Home » Topics » Cardiovascular, BioWorld Science

Cardiovascular, BioWorld Science
RSS

Hokuriku describes new calcium agonist derived from intracellular calcium antagonist

Dec. 12, 1997

LXR discovers new apoptosis-related proteins and genes

Dec. 12, 1997

E-5531: a synthetic endotoxin antagonist developed at Eisai

Dec. 11, 1997

BioCryst selects clinical candidate from serine protease inhibitor program

Dec. 10, 1997

Preferential suppression of cytokine production in monocytes by CNI-1493

Dec. 10, 1997

Meta-analysis assesses effects of amiodarone on mortality in post-MI and CHF patients

Dec. 10, 1997

Candesartan introduced in U.K., Germany

Dec. 5, 1997

Endothelin-modulating compounds developed at Texas Biotechnology

Dec. 5, 1997

Gensia Laboratories receives generic approval

Dec. 5, 1997

Valsartan approved in Canada

Dec. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...